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The allergenicities of tropomyosins from different organisms have been reported to vary. The cDNA encoding
German cockroach tropomyosin (Bla g 7) was isolated, expressed, and characterized previously. In the present
study, the amino acid sequence variations in German cockroach tropomyosin were analyzed in order to
investigate its influence on allergenicity. We also undertook the identification of immunodominant peptides
containing immunoglobulin E (IgE) epitopes which may facilitate the development of diagnostic and immu-
notherapeutic strategies based on the recombinant proteins. Two-dimensional gel electrophoresis and immu-
noblot analysis with mouse anti-recombinant German cockroach tropomyosin serum was performed to inves-
tigate the isoforms at the protein level. Reverse transcriptase PCR (RT-PCR) was applied to examine the
sequence diversity. Eleven different variants of the deduced amino acid sequences were identified by RT-PCR.
German cockroach tropomyosin has only minor sequence variations that did not seem to affect its allergenicity
significantly. These results support the molecular basis underlying the cross-reactivities of arthropod tropo-
myosins. Recombinant fragments were also generated by PCR, and IgE-binding epitopes were assessed by
enzyme-linked immunosorbent assay. Sera from seven patients revealed heterogeneous IgE-binding responses.
This study demonstrates multiple IgE-binding epitope regions in a single molecule, suggesting that full-length
tropomyosin should be used for the development of diagnostic and therapeutic reagents.
The tropomyosins are a family of closely related proteins
with multiple functions, including the regulation of the actin-
myosin interaction, transport of mRNA (8), and mechanical
support of the cytoplasmic membrane (19). Tropomyosin has
been recognized as one of the most important allergens in
crustacean foods (7, 20, 27). It is highly conserved, to the extent
that tropomyosin may serve as a candidate marker for phylo-
genetic studies of mollusks by parsimony analysis (4). Allergic
reactions to shellfish and mollusks are often cross-reactive,
which may be explained by the highly conserved amino acid
sequences of tropomyosins, but vertebrate tropomyosin is not
known to be allergenic (2). Comparisons of the immunoglob-
ulin E (IgE) epitope regions among tropomyosins from differ-
ent molluscs by Ishikawa et al. (11) showed the presence of
polymorphic sites, indicating that the oyster epitope is species
specific (18). The presence of unique as well as shared epitopes
in Blo t 10 and Der p 10 have also been described (34).
At least 18 different isoforms are known to be generated by
alternative RNA splicing in mammalian cells. The synthesis of
isoforms is developmentally regulated, and cells from different
embryonic lineages express different isoforms (26). The alter-
nate exon splicing patterns of Drosophila melanogaster were
reported to involve 27 amino acids at the C terminus (3), which
frequently contain IgE-binding regions (24). Specifically, eight
different IgE-binding epitopes were identified in the American
cockroach tropomyosin (Per a 7) by using a set of overlapping
synthetic peptides (1).
The amino acid sequence diversity of individual allergens
has been described in wild or cultured house dust mites (5, 29,
30, 32, 35) or storage mites (16). Small changes in the amino
acid sequences of given allergens can influence their allerge-
nicities (10). For example, certain natural isoforms of Bet v 1,
the major birch pollen allergen, were found to have high T-cell
reactivities and low or no IgE-binding activities (21). Analysis
of these isoforms may lead us to a better understanding of the
different allergenicities of many invertebrate tropomyosins and
the development of immunotherapeutic strategies and prod-
ucts, such as hypoallergenic (low IgE-binding activity) products.
We have previously isolated the cDNA encoding German
cockroach tropomyosin (15) and named it Bla g 7, according to
the guidelines of the International Union of Immunological
Societies Allergen Nomenclature Subcommittee (17). Recom-
binant tropomyosin expressed in Escherichia coli showed low
levels of IgE-binding reactivity. Recombinant tropomyosin was
also expressed as a nonfusion protein in Pichia pastoris, and its
IgE reactivity was compared with that of its native counterpart.
The structural differences of native and recombinant proteins
did not seem to influence significantly the IgE reactivities of
tropomyosins (14).
In order to better understand the different allergenicities of
German cockroach tropomyosin, the cDNA sequence varia-
tions in German cockroach tropomyosin were investigated by
reverse transcriptase PCR (RT-PCR). Fragmented recombi-
nant proteins were also produced, and their IgE-binding reac-
tivities were examined.
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Preparation of polyclonal anti-German cockroach tropomyosin antiserum.
BALB/c mice were intraperitoneally injected with 30 g of recombinant tropo-
myosin, which was expressed in E. coli BL21(DE3) and purified by Ni-nitrilotri-
acetic acid (NTA)-agarose (Qiagen, Valencia, Calif.), according to the instruc-
tions of the manufacturer (15), in 100 l of phosphate-buffered saline emulsified
with an equal volume of alum adjuvant. Booster injections were given twice at
3-week intervals. The production of specific antibodies was monitored by en-
zyme-linked immunosorbent assay (ELISA), and the mice were killed 3 days
after the second booster injection. The polyclonal antitropomyosin antiserum
(1:1,000) was used to probe and identify the German cockroach tropomyosin.
Two-dimensional gel electrophoresis and immunoblotting. Two-dimensional
gel electrophoresis was performed with precast gels (Invitrogen, Carsbad, Calif.),
according to the instructions of the manufacturer. Cockroach extract was pre-
pared as described previously (15). Fifty micrograms of whole-body extracts
mixed with an equal volume of the sample buffer was loaded into the first-
dimension gel. After isoelectric focusing (pH 3 to 10), second-dimension gel
electrophoresis was carried out in a 4 to 20% gradient polyacrylamide gel con-
taining sodium dodecyl sulfate. The proteins were then electrophoretically trans-
ferred onto a nitrocellulose membrane (pore size, 0.45 m; Osmonics, Westbor-
ough, Mass.). After the membrane was blocked overnight with 3% skim milk, it
was incubated for 1 h with mouse anti-recombinant Bla g 7 serum. The blots were
then incubated with goat anti-mouse IgG conjugated with alkaline phosphatase
(Sigma, St. Louis, Mo.) for 1 h at room temperature and developed in a substrate
solution of Nitro Blue Tetrazolium and 3-bromo-4-chloro-5-indolyl-phosphate
(Promega, Madison, Wis.).
RT-PCR. cDNA encoding tropomyosin was amplified by using high-fidelity Pfu
DNA polymerase (Stratagene, La Jolla, Calif.). A total of 150 mg of a German
cockroach was pulverized in liquid nitrogen with a mortar and pestle, and total
RNA was extracted by using the TRIzol reagent (Invitrogen), according to the
manual prepared by the manufacturer. Reverse transcription was initiated with
6 g of total RNA and an oligo(dT) (18 T residues) primer. Five microliters of
single-stranded cDNA was used for each reaction. The primer sequences used
were as follows: forward primer, 5-ATGGATGCCATCAAGAAGAAG-3; re-
verse primer, 5-GTTTAGTTGCCAATAAGTTCGG-3. The cDNA encoding
tropomyosin from different cockroach species (Periplaneta fuliginosa), as well as
Blattella germanica, was successfully cloned by RT-PCR with this specific primer
set (13, 15). PCR was performed as follows: after an initial denaturation (5 min
at 95°C), the samples were subjected to 35 cycles of amplification, each of which
consisted of 1 min at 95°C, 1 min at 55°C, and 2 min at 72°C. The final extension
was performed at 72°C for 8 min. The DNA fragment so obtained was cloned
into a pPCR Script Amp SK (Stratagene) vector.
Nucleotide sequence determination. A ThermoSequenase kit (Amersham Life
Science, Cleveland, Ohio) was used for nucleotide sequence determination.
Reaction mixtures were run on a Long ReadIR 4200 DNA sequencer (LI-COR,
Inc., Lincoln, Nebr.). All reactions (both forward and reverse) were performed
in duplicate.
Generation of fragments by PCR amplification. For epitope analysis, rBla g 7
was divided into five fragments containing 50 overlapping amino acids, i.e.,
fragments A (residues 1 to 100), B (residues 51 to 150), C (residues 101 to 200),
D (residues 151 to 250), and E (residues 201 to 284) (Fig. 1). The oligonucleo-
tides used in the PCR are listed in Table 1. Each cDNA fragment was amplified
by PCR and ligated into the pGEM-T Easy vector (Promega). The cDNA of Bla
g 7 cloned in pET-28b was used as the template, and restriction enzyme cleavage
sites were incorporated into each oligonucleotide primer to create restriction
sites for subcloning (BamHI for forward primers and XhoI for reverse primers).
The PCR was carried out with an initial denaturation at 95°C for 5 min and then
35 cycles of amplification were done under following conditions: denaturation at
94°C for 30 s, annealing at 52°C for 30 s, and extension at 72°C for 1 min. The
PCR product was cloned into the pGEM-T Easy vector (Promega) and, after
restriction digestion, into the pET-28b vector. Recombinant proteins were ex-
pressed in E. coli BL21(DE3) and purified by Ni-NTA agarose (Qiagen) affinity
column chromatography.
Subjects and serum samples. Sera from patients attending the Allergy Clinic
of the Severance Hospital, Yonsei University, Seoul, Korea, were tested for the
presence of IgE antibody against B. germanica by using the Uni-CAP system
(Pharmacia, Uppsala, Sweden). Those with Uni-Cap results higher than 0.7
kU/liter were tested again for the presence of recombinant tropomyosin-specific
IgE antibodies by ELISA, as described previously (15). Eight serum samples
were selected for the epitope study (subject age range, 1 to 22 years; average age,
11 years). The diagnosis of allergy was based on case history and a skin-prick test.
IgE epitope analysis of subjects’ sera. The reactivities of specific IgE antibod-
ies to fragmented recombinant Bla g 7 were examined by ELISA with seven
serum samples obtained from recombinant Bla g 7-positive patients. Purified
recombinant proteins (0.2 g/well) were coated (0.1 M sodium carbonate [pH
9.6]) onto a polystyrene microtiter plate (Corning, Corning, N.Y.) and incubated
overnight at 4°C. After the plate was blocked with 3% skim milk for 1 h, the plate
was washed with phosphate-buffered saline containing 0.05% Tween 20 and
incubated for 1 h with human serum (1:4 dilution). After the plate was washed,
IgE antibody was detected by using biotinylated goat anti-human IgE (epsilon
chain specific; Vector, Burlingame, Calif.) diluted 1:1,000 with streptavidin-
peroxidase (Sigma) diluted 1:1,000. The signal was developed by adding 3,3,5,5-
tetramethylbenzidine (Kirkegaard & Perry Laboratories, Gaithersburg, Md.),
and the optical density at 450 nm was determined after the addition of 1%
H2SO4 on an automatic microplate reader (Tecan, Salzburg, Austria). The mean
absorbance level plus 2 standard deviations for the sera from eight healthy
controls was used as the cutoff value.
RESULTS
Two-dimensional immunoblot analysis. In an attempt to
investigate the isoforms of German cockroach tropomyosin at
the protein level, whole-body extract proteins were subjected
to two-dimensional electrophoresis, followed by immunoblot-
ting with mouse anti-Bla g 7 sera (Fig. 2). Diffused spots with
molecular masses of 34 to 40 kDa and isoelectric points rang-
ing from 4.5 to 5.5 were observed. These spots suggested the
existence of many isoforms with subtle amino acid variations.
Sequence analysis of cDNA clones. A total of 11 different
variants with amino acid variations were identified by deter-
mining the sequences of the 50 clones obtained by RT-PCR.
Only slight differences were identified at seven locations in the
deduced amino acid sequences. A previously described se-
quence (GenBank accession number AF260897) was found in
38 of the 50 clones, indicating that it is a major form. This
major variant was used for further studies. The amino acid
positions that were found to vary among the Bla g 7 variants
were 81, 85, 89, 183, 234, 246, 278, and 284 (Fig. 3). The most
FIG. 1. Schematic representation of tropomyosin fragments for epi-
tope analysis of German cockroach tropomyosin.













a The underlined nucleotides of each oligonucleotide represent the restriction
enzyme site.
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frequent amino acid change was observed at residue 284 (6 of
50 clones). This observation is in agreement with the findings
from immunoblot analysis with a two-dimensional gel, which
showed diffuse spots. The IgE epitopes identified from Penaeus
aztecus tropomyosin are shown in Fig. 3. Only 2 of the 50
clones (clones pm043 and pm061) were found to have amino
acid sequence variations in the IgE epitope regions.
An analysis of IgE epitopes was carried out because these
variations were not thought to significantly influence IgE-bind-
ing reactivity.
IgE reactivities of recombinant peptides by ELISA. Recom-
binant fragments of Bla g 7 were expressed in E. coli and
assayed for their IgE reactivities (Fig. 4). The IgE reactivities
to intact Bla g 7 and recombinant proteins were determined by
ELISA with Bla g 7-sensitized sera (Fig. 5) and are summa-
rized in Table 2. The results obtained showed that IgE-binding
regions were heterogeneously distributed among the different
serum samples. The IgE antibodies from patients 5 and 6 were
able to bind to all recombinant proteins tested, indicating that
the serum of a single patient can recognize at least three
different IgE-binding epitopes. IgE antibodies from patients 1,
4, 5, and 6 were able to recognize fragments A and B; and the
IgE antibodies of patients 5, 6, and 7 were able to recognize
fragment C. The IgE antibodies of patients 3, 4, 5, 6, and 7
recognized fragments D and E. The IgE antibody from patient
2 recognized fragment E only.
DISCUSSION
Tropomyosin has been recognized as one of the most im-
portant allergens in crustacean foods (7, 20, 27). It is highly
conserved, to the extent that tropomyosin may serve as a can-
didate marker for phylogenetic studies of mollusks by parsi-
mony analysis (4). Allergic reactions to shellfish and mollusks
FIG. 2. Two-dimensional immunoblot analysis of German cock-
roach tropomyosin with mouse anti-rBla g 7 sera. The numbers on the
left indicate the sizes of the molecular mass standards (in kilodaltons).
FIG. 3. Amino acid sequence variations in German cockroach tropomyosin identified by RT-PCR. The frequency of each sequence is shown
in parentheses. Shaded areas indicate the IgE-binding epitopes identified from P. aztecus tropomyosin.
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are often cross-reactive, which may be explained by the highly
conserved amino acid sequences of mollusk tropomyosin, but
vertebrate tropomyosin is not known to be allergenic (2). Com-
parisons of the IgE epitope regions among tropomyosins from
different mollusks by Ishikawa et al. (11) showed the presence
of polymorphic sites, indicating that the oyster epitope is spe-
cies specific (18). The presence of unique as well as shared
epitopes in Blo t 10 and Der p 10 has also been described (34).
IgE is thought to be a key molecule in the mediation of many
allergic diseases (22). It was reported that the IgE-binding
capacity of the German cockroach extract was totally abolished
by Atlantic shrimp extract, which was found to have strong
IgE-binding components between 30 and 43 kDa (presumably
tropomyosin) by IgE blot inhibition (6). However, in the pre-
vious study (6), recombinant German cockroach tropomyosin
was able to inhibit only 32.4% of IgE binding to cockroach
extract (15).
The first approach required in the study of the relationship
between structure and allergenicity is epitope identification. At
present the SPOTs system (Genosys, The Woodland, Tex.) and
the Novatope system (Novagen, Madison, Wis.) are extensively
used to identify IgE-binding epitopes, and the results obtained
with the two systems have been extensively compared (25).
Moreover, fragmented peptides are reported to have higher
IgE-binding capacities than whole molecules in the case of
paramyosin, Der f 11 (33). These were not real peptide frag-
ments presented by professional phagocytes of the immune
system; however, these peptide fragments could have been
made by the proteolytic enzymes derived from mites or the
cockroaches themselves.
In the present study, we tried to determine whether the low
allergenicity of German cockroach tropomyosin is affected or
not by amino acid sequence variations of its isoforms. For
convenience, the German cockroach tropomyosin amino acid
sequences deduced from RT-PCR analysis were compared
with those of P. aztecus tropomyosin (Fig. 3). Only two variant
German cockroach tropomyosins resulting from amino acid
substitutions in the IgE epitope regions were different from
P. aztecus tropomyosin, which is one of the well-studied tro-
pomyosin molecules (1), and 11 different amino acid sequence
variations were identified (Fig. 3). The IgE-binding reactivities
of intact or fragmented Bla g 7 were analyzed to investigate
IgE epitopes in the Korean patient population (Fig. 5). All sera
tested showed different patterns of IgE reactivity. Analyses of
IgE epitopes from different patient groups or tropomyosin
from different organisms showed that the epitopes exhibited
different IgE-binding regions (1, 12, 23, 27), which implies the
presence of various epitope regions, which are influenced by
genetic backgrounds and environmental factors. The structural
basis for bending tropomyosin around actin filaments is attrib-
uted to the structural regularity of the molecule (31). The
tropomyosin coiled coil consists of two -helices, which are
characterized by the occurrence of tandem (heptad) repeats
(28). The structural regularity of tropomyosin may be a possi-
ble explanation for the existence of multiple IgE-binding epi-
topes. Specific immunotherapy is an efficient treatment for
subjects with IgE-mediated allergic reactions. Studies of IgE
epitopes have led to a better understanding of the mechanisms
underlying successful immunotherapy and the proposed use of
hypoallergenic forms of allergens for immunotherapy (9).
In conclusion, the low allergenicity of previously reported
German cockroach tropomyosin does not seem to be due to
amino acid sequence variations. The IgE-binding epitope re-
gions were found to be distributed over the whole molecule. It
FIG. 4. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
of full-length and fragmented recombinant Bla g 7. Lanes: M, molec-
ular mass standard; F, full-length fragment; A, fragment of 1 to 100
amino acid; B, fragment of 51 to 150 amino acids; C, fragment of 101
to 200 amino acids; D, fragment of 151 to 250 amino acids; E, fragment
of 201 to 284 amino acids; S, bovine serum albumin.
FIG. 5. Profiles of IgE antibody binding to recombinant Bla g 7 and
relevant recombinant proteins obtained by ELISA. Dotted line, cutoff
value (mean absorbance plus 2 standard deviations for the sera from
eight healthy controls); 1 to 7, serum samples from seven allergic pa-
tients, respectively; N, Bla g 7-negative serum sample; B, buffer con-
trol.
TABLE 2. IgE-binding reactivities of peptide fragments of
German cockroach tropomyosin
Fragment
IgE binding in subject:
1 2 3 4 5 6 7
Full length       
A       
B       
C       
D       
E       
BSAa       
a BSA, bovine serum albumin.
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is not advisable to use a fragment for diagnostic or therapeutic
purposes in case of tropomyosin. Invertebrate tropomyosin
could provide a molecular model for investigation of the ge-
netic and environmental factors affecting sensitization and the
onset of allergic disorders.
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